Our findings further support this: regional gradient alterations in LBD aligned with the regional distribution of PD- but not AD-specific gene lists, and divergence from normative gradient ratings did not correlate with plasma p-tau levels. This evidence concerns the gene MAPT and Alzheimer disease.